Stomach Paralysis After Ozempic: When Food Just Sits There

Marin & MurphySuper Lawyers® 2014–2024(888) 348-2735

Ozempic (GLP-1) Lawsuit — Free Case Review

Your Stomach Symptoms Were Real

If you took brand-name Ozempic, Wegovy, or Rybelsus and were diagnosed with a tested, documented stomach injury with an ER or hospital visit, you may qualify.

No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state.

Did this happen to you — or someone you love?

Start your free case reviewTell us anyway

Answered 24/7 · Free & confidential · No fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney's fee is a percentage of the gross recovery, calculated before expenses are deducted.

(888) 348-2735

Partners

Matthew T. Marin & Stefanie A. Murphy

Super Lawyers® honorees · American Association for Justice members

Ozempic inquiries get a personal review — and an honest answer either way, free and without obligation.

No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state. Do not stop, start, or change any prescribed medication because of anything on this page. Those decisions belong with your prescriber. Attorney Advertising.

“Stomach paralysis” is the everyday name for gastroparesis — a condition in which the stomach empties far too slowly, so food sits for hours, comes back up, and eating becomes something you have to plan around. People who took Ozempic, Wegovy, or Rybelsus and were later diagnosed with it are part of a nationwide litigation: federal GLP-1 stomach-injury cases are consolidated in MDL 3094 in the Eastern District of Pennsylvania, where 4,022 cases were pending as of September 2026. Since August 15, 2025, that court has required a gastroparesis diagnosis to be supported by a gastric emptying study.

Reports submitted to FDA are not verified and do not establish causation.

What people mean when they say “stomach paralysis”

Almost nobody leaves an appointment saying “I have delayed gastric emptying.” They say the food is just sitting there. They say they threw up something they ate the night before. They say they felt full all the time, and then that they were scared to eat, because you never know what will set it off.

The clinical word is gastroparesis: the stomach’s muscular wall doesn’t move contents along as it should, so meals linger instead of passing into the small intestine. That produces a specific, exhausting pattern — fullness after a few bites, nausea that doesn’t lift, vomiting hours after eating, weight coming off faster than anyone planned, weakness, and in longer cases dental damage from stomach acid. Solids are usually worse than liquids.

If you have been told this is anxiety, or an eating disorder, or that you should try eating smaller meals and stop worrying — you are not the first person to be told this was in your head. That experience is close to universal in this group, and it is one reason people wait years before looking anything up.

The drug worked. That’s what makes this hard.

For a lot of people reading this, the medication did exactly what it was supposed to do. The weight came off. The A1c came down. Then something went wrong with the stomach, and now the two facts sit next to each other and refuse to resolve.

You can be grateful it worked and still be owed the truth about what it did. Whatever your reason for taking it — that isn’t what this is about. What matters is what you were told about the risks, and what you weren’t. Some people reading this are still taking it, which is a reasonable position given what is known about weight returning after people stop. Wanting to keep taking it doesn’t make you wrong about what happened, and it doesn’t affect whether your facts are worth reviewing.

What the label said, and when

Slowed stomach emptying is no surprise to the manufacturers — it is described in the Clinical Pharmacology section of these labels as part of how the drug works. In September 2023, FDA added ileus (intestinal blockage) to the Ozempic label as a post-marketing adverse reaction. But “gastroparesis” has never been added as a named term to the US labels, and that gap is the core of the plaintiffs’ argument: the warning a patient and prescriber could actually read did not name the condition people were being diagnosed with. The manufacturers dispute this, saying the label already disclosed nausea, vomiting, delayed gastric emptying, ileus and obstruction, and that FDA reviewed the labeling many times and made its own judgment. No court has decided who is right.

Where the litigation actually stands

Federal stomach-injury cases against Novo Nordisk and Eli Lilly are consolidated before Judge Karen S. Marston in the Eastern District of Pennsylvania as MDL 3094; 4,022 were pending as of the JPML report dated September 1, 2026. The court has set no trial date and selected no bellwether cases. Instead it front-loaded three “cross-cutting issues” — how gastroparesis is reliably diagnosed, whether the warnings were adequate or the claims preempted, and whether these drugs are capable of causing the injuries alleged. A hearing on expert evidence for the second and third is scheduled for September 14–18, 2026. Its outcome is not predictable, and we won’t pretend otherwise.

The one test that decides most stomach cases

On August 15, 2025, the court entered an order (Doc. 468) holding that any plaintiff claiming gastroparesis must show that the diagnosis is based on a properly performed gastric emptying study — scintigraphy, a breath test, or a wireless motility capsule.

The part that matters to you personally: most people told they have gastroparesis were never given that test. They were diagnosed on symptoms, which is how American medicine ordinarily handles this condition — a gap in normal practice, not a reflection on you or your doctor. It doesn’t mean you were wrong. It means there is a step to complete. We explain the test, and what to do if you never had one, here.

Who may qualify today

• Brand-name Ozempic, Wegovy, or Rybelsus. Compounded or generic semaglutide, and Mounjaro, Zepbound or Trulicity, don’t fit today’s stomach-injury criteria — tell us anyway; criteria differ by track.
• Gastroparesis confirmed by a gastric emptying study, or gastric obstruction confirmed by other objective testing.
• Diagnosed while taking the medication, or within about 30 days of stopping.
• Diagnosed before December 31, 2024.
• An emergency room visit or hospital admission connected to the injury.
• Age 75 or under at intake, and not already represented by another lawyer for this issue.
• Not sure what testing you had? That is the most common honest answer there is. Tell us anyway — we can help you work out what your records show.

You are not suing your doctor

This is a claim against the companies that made and labeled the medication — Novo Nordisk and Eli Lilly. It is not a claim against your doctor, your pharmacist, or your clinic. Your prescriber wrote for what the label said was safe. In many of these cases the prescriber’s records are the single most helpful thing a claimant has.

Common questions

Related stomach-injury topics: bowel obstruction & ileus, feeding tubes, constant vomiting & ER visits, and the gastric emptying study.